Artificial intelligence presents opportunities, challenges in neurologic practiceNovember 14, 2023Business of MedicineNeuromuscular DisordersAlzheimer's & CognitionEpilepsy & SeizuresHeadache & MigraineMovement DisordersMultiple Sclerosis
RNA therapeutics will ‘change everything’ in epilepsyNovember 8, 2023Epilepsy & SeizuresRare DiseasesPediatrics
Global burden of brain disorders surpasses cardiovascular disease and cancerJuly 12, 2023Alzheimer's & CognitionStrokeHeadache & MigraineEpilepsy & SeizuresMultiple SclerosisParkinson's Disease
New DEA CME mandate affects 2 million prescribersJune 27, 2023PainEpilepsy & SeizuresBusiness of Medicine
Thirty years of epilepsy therapy: ‘Plus ça change, plus c’est la même chose’?April 18, 2023Epilepsy & Seizures
Minorities with epilepsy blocked from receiving ‘highest quality of care’January 26, 2023Epilepsy & SeizuresDiversity in Medicine
Antiepileptic drugs tied to increased Parkinson’s disease riskJanuary 3, 2023Epilepsy & SeizuresParkinson's DiseaseMovement Disorders
